| Irritable Bowel Syndrome |
1 |
1 |
| Clinical Guidelines |
0 |
0.99 |
| Diarrhea |
0 |
0.37 |
| Cyclic Antidepressants |
0 |
0.34 |
| Shared Decision-Making |
0 |
0.3 |
| Depression |
0 |
0.26 |
| Antidepressant drug |
0 |
0.15 |
| Generics |
0 |
0.15 |
| Abdominal Pain |
0 |
0.13 |
| Pain Management |
0 |
0.09 |
| Abdomen |
0 |
0.07 |
| Adverse Effects |
0 |
0.07 |
| Clinician Health and Well-Being |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Laxatives |
0 |
0.07 |
| Minnesota |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.07 |
| Constipation |
0 |
0.05 |
| Medical Life |
0 |
0.05 |
| Patient Safety |
0 |
0.05 |